Drugs / faecal microbiota transplantation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06461208 | Jun 2023 → Jan 2028 expected | cirrhosis of liver | King's College London | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | faecal microbiota transplantation | “It could be beneficial to replace the unfriendly bowel bacteria in patients with cirrhosis with bacteria donated from a healthy person by performing a type of bowel bacteria...” NCT06461208 ↗ |
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06461208 ↗ |
| Modality | Other / unclassified | “faecal microbiota transplantation” NCT06461208 ↗ |